In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics - Tang, C; Shou, M; Rushmore, TH; Mei, Q; Sandhu, P; Woolf, EJ; Rose, MJ; Gelmann, A; Greenberg, HE; De Lepeleire, I; Van Hecken, A; De Schepper, PJ; Ebel, DL; Schwartz, JI; Rodrigues, AD (Pharmacogenetics, 2001)